Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	880.79	157.23	11.37	286.02	116.08	62.01
Cash & Short-Term Investments	880.79	157.23	11.37	286.02	116.08	62.01
Cash Growth	354.12%	1283.12%	-96.03%	146.40%	87.18%	45.52%
Accounts Receivable	3,240	3,146	3,299	2,055	1,516	1,245
Other Receivables	24.26	15.71	-	-	-	-
Receivables	3,271	3,165	3,303	2,057	1,519	1,248
Inventory	2,297	2,169	2,005	1,835	1,156	944.05
Prepaid Expenses	-	13.11	8.61	9.5	8.51	5.8
Other Current Assets	823.43	741.2	676.9	454.29	407.93	346.43
Total Current Assets	7,272	6,245	6,005	4,641	3,208	2,606
Property, Plant & Equipment	5,127	5,215	4,603	3,285	1,554	1,129
Long-Term Investments	17.84	17.84	17.84	7.84	0.08	0.08
Other Intangible Assets	62.66	63.44	56.19	6.79	6.1	4.45
Long-Term Deferred Tax Assets	-	-	-	9.66	-	-
Other Long-Term Assets	223.14	150.33	239.13	658.02	443.58	178.1
Total Assets	12,711	11,694	10,925	8,612	5,214	3,921
Accounts Payable	1,989	1,587	1,663	1,303	1,410	1,112
Accrued Expenses	-	197.36	184.07	143.78	172.45	191.99
Short-Term Debt	-	1,543	1,420	1,118	65.99	163.24
Current Portion of Long-Term Debt	2,286	256.08	210.54	89.67	66.65	35.98
Current Portion of Leases	65.42	62.27	43.26	65.76	28.17	33.66
Current Income Taxes Payable	-	-	25.45	31.24	6.75	15.82
Other Current Liabilities	356.27	229.7	174.31	131.37	114.5	83.79
Total Current Liabilities	4,697	3,876	3,720	2,882	1,864	1,637
Long-Term Debt	1,178	1,305	1,540	1,907	479.78	354.27
Long-Term Leases	162.39	195.93	115.55	162.1	3.29	28.22
Pension & Post-Retirement Benefits	-	105.32	90.59	77.75	65.88	51.34
Long-Term Deferred Tax Liabilities	117.97	77.72	20.63	-	1.9	14.9
Other Long-Term Liabilities	244.02	123.34	112.92	104.8	107.98	100.9
Total Liabilities	6,399	5,683	5,600	5,134	2,523	2,186
Common Stock	100.28	100.28	100.28	96.95	96.95	96.95
Additional Paid-In Capital	-	996.57	996.57	-	-	-
Retained Earnings	-	4,223	3,538	2,686	1,899	950.31
Comprehensive Income & Other	6,211	690.49	690.72	694.76	695.22	687.11
Shareholders' Equity	6,312	6,011	5,326	3,478	2,691	1,734
Total Liabilities & Equity	12,711	11,694	10,925	8,612	5,214	3,921
Total Debt	3,692	3,362	3,329	3,342	643.87	615.37
Net Cash (Debt)	-2,811	-3,205	-3,318	-3,056	-527.79	-553.36
Net Cash Per Share	-28.03	-31.96	-33.68	-31.52	-5.44	-5.71
Filing Date Shares Outstanding	100.14	100.28	100.28	96.94	96.94	96.94
Total Common Shares Outstanding	100.14	100.28	100.28	96.94	96.94	96.94
Working Capital	2,575	2,370	2,284	1,759	1,344	969.2
Book Value Per Share	63.02	59.94	53.11	35.88	27.76	17.89
Tangible Book Value	6,249	5,947	5,269	3,471	2,685	1,730
Tangible Book Value Per Share	62.40	59.31	52.55	35.81	27.70	17.84
Land	-	103.9	98.9	-	-	-
Buildings	-	1,230	383.55	417.59	355.81	235.49
Machinery	-	4,167	1,516	1,534	1,229	1,119
Construction In Progress	-	218.16	3,071	1,696	408.74	134.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.